ATE359508T1 - Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke - Google Patents

Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke

Info

Publication number
ATE359508T1
ATE359508T1 AT05708384T AT05708384T ATE359508T1 AT E359508 T1 ATE359508 T1 AT E359508T1 AT 05708384 T AT05708384 T AT 05708384T AT 05708384 T AT05708384 T AT 05708384T AT E359508 T1 ATE359508 T1 AT E359508T1
Authority
AT
Austria
Prior art keywords
zebrafish
blood
brain barrier
screening methods
brain
Prior art date
Application number
AT05708384T
Other languages
English (en)
Inventor
Paul Goldsmith
Angeleen Louise Fleming
Original Assignee
Daniolabs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32039873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE359508(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daniolabs Ltd filed Critical Daniolabs Ltd
Application granted granted Critical
Publication of ATE359508T1 publication Critical patent/ATE359508T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
AT05708384T 2004-02-17 2005-02-17 Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke ATE359508T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0403490.6A GB0403490D0 (en) 2004-02-17 2004-02-17 Screening methods

Publications (1)

Publication Number Publication Date
ATE359508T1 true ATE359508T1 (de) 2007-05-15

Family

ID=32039873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05708384T ATE359508T1 (de) 2004-02-17 2005-02-17 Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke

Country Status (10)

Country Link
US (1) US20060193776A1 (de)
EP (1) EP1644733B1 (de)
JP (1) JP2007525665A (de)
AT (1) ATE359508T1 (de)
AU (1) AU2005215455A1 (de)
CA (1) CA2556680A1 (de)
DE (1) DE602005000874T2 (de)
ES (1) ES2286794T3 (de)
GB (1) GB0403490D0 (de)
WO (1) WO2005080974A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656449B1 (en) * 1998-02-23 2003-12-02 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
JP4383533B2 (ja) 1998-02-23 2009-12-16 フィロニクス ファーマシューティカルズ， インコーポレイテッド 真骨魚類を使用する、活性についての薬剤のスクリーニング方法
US7951989B2 (en) * 1998-02-23 2011-05-31 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US20060018833A1 (en) * 2004-04-07 2006-01-26 Randall Murphy Method and system for screening compounds for muscular and/or neurological activity in animals
DK2329265T3 (da) * 2008-09-22 2013-12-02 Entomopharm Aps Fremgangsmåder til screening, hvor der anvendes insekter med blodhjernebarriere
WO2011077733A1 (ja) 2009-12-25 2011-06-30 キヤノン株式会社 経鼻中枢神経系組織標識用組成物、経鼻中枢神経系組織標識用組成物を用いた標識方法及びスクリーニング方法
JP5733716B2 (ja) * 2009-12-25 2015-06-10 キヤノン株式会社 中枢神経系組織標識用組成物、中枢神経系組織の標識方法、及び中枢神経系組織標識用組成物を用いたスクリーニング方法
JP5888904B2 (ja) 2011-02-16 2016-03-22 国立大学法人三重大学 中枢神経移行性評価用プローブ、中枢神経移行性評価方法、及び、中枢神経移行性評価用プローブを用いたスクリーニング方法
CN102288750B (zh) * 2011-08-12 2014-04-16 杭州环特生物科技有限公司 斑马鱼p-糖蛋白抑制剂筛选模型的建立方法及其应用
AU2018221731C1 (en) 2017-02-17 2021-11-18 Denali Therapeutics Inc. Engineered transferrin receptor binding polypeptides
US10143187B2 (en) 2017-02-17 2018-12-04 Denali Therapeutics Inc. Transferrin receptor transgenic models
US10457717B2 (en) 2017-02-17 2019-10-29 Denali Therapeutics Inc. Engineered polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4383533B2 (ja) * 1998-02-23 2009-12-16 フィロニクス ファーマシューティカルズ， インコーポレイテッド 真骨魚類を使用する、活性についての薬剤のスクリーニング方法

Also Published As

Publication number Publication date
EP1644733A1 (de) 2006-04-12
WO2005080974A1 (en) 2005-09-01
EP1644733B1 (de) 2007-04-11
US20060193776A1 (en) 2006-08-31
ES2286794T3 (es) 2007-12-01
GB0403490D0 (en) 2004-03-24
DE602005000874T2 (de) 2008-01-17
DE602005000874D1 (de) 2007-05-24
JP2007525665A (ja) 2007-09-06
AU2005215455A1 (en) 2005-09-01
CA2556680A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
ATE359508T1 (de) Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke
DE602005025106D1 (de) Methoden zur medikamentenaufspürung auf der basis von in vitro differenzierten zellen
ATE457773T1 (de) Mittel zur funktionalen wiederherstellung eines geschädigten nervensystems
ATE397676T1 (de) Identifikation und verwendung von mirnas zur differenzierung myelogener leukämiezellen
NO20092741L (no) DR6-antagonister og anvendelse derav ved behandling av neurologiske forstyrrelser
ATE525648T1 (de) Testelement mit nanofasern
DE602004009171D1 (de) Methode und vorrichtung zur verbesserung des ventrikulären status unter verwendung der kraft-intervall-beziehung
ATE465412T1 (de) Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen
WO2007084979A3 (en) Method to quantitatively measure effect of psychotropic drugs on sensory discrimination
ATE462140T1 (de) Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate
GB2473575A (en) Treatment and diagnosis of behavioural disorders
DE602006018461D1 (de) Galk1s als modifikatoren des pten/akt-wegs
WO2006009962A3 (en) Acacs as modifiers of the igf pathway and methods of use
DE602006020224D1 (de) Kleine Vorrichtung zur Analyse von Genen
WO2006009924A3 (en) Pfks as modifiers of the igfr pathway and methods of use
WO2005072241A3 (en) Inhibition of bright function as a treatment for excessive immunoglobulin production
EP1723415A4 (de) Pdes als modifikatoren des igfr-wegs und verwendungsverfahren
WO2005010148A3 (en) Marks as modifiers of the pten pathway and methods of use
WO2005072475A3 (en) Itpks as modifiers of the igfr pathway and methods of use
WO2006036613A3 (en) Mracs as modifiers of the rac pathway and methods of use
DE602006020601D1 (de) Verfahren zur verwendung von il-21
MX2010007539A (es) Aislado de huevo fertilizado y uso del mismo.
WO2007024946A3 (en) Methods for the treatment of anxiety and for identification of anxiolytic agents
WO2007058933A3 (en) Melks as modifiers of the rho pathway and methods of use
WO2005090992A3 (en) Mptens as modifiers of the pten pathway and methods of use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties